1000-467X
2013 Issue 6
..............page:357
Efficacy of minimally invasive therapies on unresectable pancreatic cancer
Zhi-Mei Huang 1;2*;Chang-Chuan Pan 3*;Pei-Hong Wu 1;2;Ming Zhao 1;2;Wang Li 1;2;Zi-Lin Huang 1;2 and Rui-Yang Yi 4Authors′ Affiliatiοns: 1 State Key Loboratory of Oncology in South China;2 Division of Medical Imaging and Interventional Radiology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P. R. China;3 Medical Oncology;Sichuan Cancer Hospital & Institute;The Second People′ s Hospital of Sichuan Province;Chengdu;Sichuan 610041;P. R. China;4 Undergraduate College;The University of Chicago;Chicago;IL 60615;USA.
Zhi-Mei Huang 1;2*;Chang-Chuan Pan 3*;Pei-Hong Wu 1;2;Ming Zhao 1;2;Wang Li 1;2;Zi-Lin Huang 1;2 and Rui-Yang Yi 4Authors′ Affiliatiοns: 1 State Key Loboratory of Oncology in South China;2 Division of Medical Imaging and Interventional Radiology;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P. R. China;3 Medical Oncology;Sichuan Cancer Hospital & Institute;The Second People′ s Hospital of Sichuan Province;Chengdu;Sichuan 610041;P. R. China;4 Undergraduate College;The University of Chicago;Chicago;IL 60615;USA.
..............page:334-341
The VEGF signaling pathway in cancer: the road ahead
Steven A. Stacker 1;2 and Marc G. Achen 1;2Authors′ Affiliatiοns: 1 Tumour Angiogenesis Program;Peter MacCallum Cancer Centre;St. Andrews Place;East Melbourne;Victoria 3002;Australia. 2 Sir Peter MacCallum Department of Oncology;University of Melbourne;Parkville;Victoria 3050;Australia.
Steven A. Stacker 1;2 and Marc G. Achen 1;2Authors′ Affiliatiοns: 1 Tumour Angiogenesis Program;Peter MacCallum Cancer Centre;St. Andrews Place;East Melbourne;Victoria 3002;Australia. 2 Sir Peter MacCallum Department of Oncology;University of Melbourne;Parkville;Victoria 3050;Australia.
..............page:297-302
Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features
Kanishka Sircar 1;Priya Rao 1;Eric Jonasch 2;Federico A. Monzon 3 and Pheroze Tamboli 1Authors′ Affiliations: Departments of 1 Pathology and 2 Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers;The University of Texas MD Anderson Cancer Center;Houston;TX 77030;USA;3 Department of Pathology and Immunology and Department of Human and Molecular Genetics;Baylor College of Medicine;Houston;TX 77030;USA.
Kanishka Sircar 1;Priya Rao 1;Eric Jonasch 2;Federico A. Monzon 3 and Pheroze Tamboli 1Authors′ Affiliations: Departments of 1 Pathology and 2 Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers;The University of Texas MD Anderson Cancer Center;Houston;TX 77030;USA;3 Department of Pathology and Immunology and Department of Human and Molecular Genetics;Baylor College of Medicine;Houston;TX 77030;USA.
..............page:303-311
Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study
Qing Liu 1;Jin-Ou Chen 2;Qi-Hong Huang 3 and Yan-Hua Li 3Authors′ Affiliations: 1 Department of Preventive Medicine;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P. R. China;2 Department of Medical Statistics and Epidemiology;School of Public Health;Sun Yat-sen University;Gaungzhou;Guangdong 510080;P. R. China;3 Sihui Institute of Cancer;Sihui;Guangdong 530000;P. R. China.
Qing Liu 1;Jin-Ou Chen 2;Qi-Hong Huang 3 and Yan-Hua Li 3Authors′ Affiliations: 1 Department of Preventive Medicine;Sun Yat-sen University Cancer Center;Guangzhou;Guangdong 510060;P. R. China;2 Department of Medical Statistics and Epidemiology;School of Public Health;Sun Yat-sen University;Gaungzhou;Guangdong 510080;P. R. China;3 Sihui Institute of Cancer;Sihui;Guangdong 530000;P. R. China.
..............page:325-333
Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
Cynthia Ro;Wanxing Chai;Victoria E. Yu and Run YuAuthors′ Affiliatiοn: Cedars-Sinai Medical Center;Los Angeles;CA 90048;USA.
Cynthia Ro;Wanxing Chai;Victoria E. Yu and Run YuAuthors′ Affiliatiοn: Cedars-Sinai Medical Center;Los Angeles;CA 90048;USA.
..............page:312-324
Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
Lin Yang;Shi-Ying Yu and Guang-Yuan HuAuthors′ Affiliation: Oncology Center;Tongji Hospital;Tongji Medical College;Huazhong Science and Technology University;Wuhan;Hubei 430030;P. R. China.
Lin Yang;Shi-Ying Yu and Guang-Yuan HuAuthors′ Affiliation: Oncology Center;Tongji Hospital;Tongji Medical College;Huazhong Science and Technology University;Wuhan;Hubei 430030;P. R. China.
..............page:353-356
The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system
Sheng-Ye Wang 1;2;Wei-Ming Mao 1;Xiang-Hui Du 1;Ya-Ping Xu 1 and Su-Zhan Zhang 2Authors′ Affiliations: 1 Department of Radiation Oncology;Zhejiang Cancer Hospital;Hangzhou;Zhejiang 310022;P. R. China;2 Department of Oncology;Τhe Second Affiliated Hospital;Zhejiang University;Hangzhou;Zhejiang 310009;P. R. China.
Sheng-Ye Wang 1;2;Wei-Ming Mao 1;Xiang-Hui Du 1;Ya-Ping Xu 1 and Su-Zhan Zhang 2Authors′ Affiliations: 1 Department of Radiation Oncology;Zhejiang Cancer Hospital;Hangzhou;Zhejiang 310022;P. R. China;2 Department of Oncology;Τhe Second Affiliated Hospital;Zhejiang University;Hangzhou;Zhejiang 310009;P. R. China.
..............page:342-352